Purchase Order HHSF223201610294A
Award Date
7/20/16
Potential Completion Date
7/21/17
Potential Value
$153K
Federal Agency
Food and Drug Administration
Awardee
Pharsight Corporation
Ultimate Awardee
Certara USA Inc.
NAICS Category
511210 - Software Publishers
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20857, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Certara USA Inc., doing business as Tripos (De), to provide annual licenses and maintenance for the Phoenix Quantum software suite. The $151,470.39 award does not have a set-aside designation. Certara, a technology-enabled drug development and drug safety consultancy, has previously received federal contracts from the FDA, NIH, and CDC to provide pharmacokinetic modeling and...
This is a $845,852.26 firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Certara USA Inc., a leading provider of biosimulation software and consulting services for the pharmaceutical industry. The contract is for the renewal of Certara's Phoenix Quantum software licenses and IVIVC Toolkits, which are essential for the FDA's Office of Clinical Pharmacology to analyze clinical pharmacology and pharmacometric data submitted by drug sponsors. The contract...
This is a $91,396 firm fixed-price purchase order issued by the Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (De), for the ratification of Phoenix Quantum licenses in fiscal year 2017. Certara is a technology-enabled drug development and drug safety consultancy that specializes in biosimulation and has received multiple federal contracts from the Department of Health and Human Services, including the FDA, National Institutes of Health, and Centers for...
This federal contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), is for $83,806.57 to provide Certara Phoenix software licenses for pharmacokinetic modeling and simulation. The contract is a firm fixed-price purchase order with a completion date of August 31, 2026. Certara is a technology-enabled drug development and drug safety consultancy that has received numerous prior federal contract...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Certara USA Inc., a leading provider of biosimulation software and consulting services. The contract, valued at $16,441.10, is for the procurement of software licenses for Certara's proprietary modeling and simulation tools, including Phoenix WinNonlin, Certara Phoenix, CHEMOFFICE, and SEND EXPLORER. These software products enable federal scientists and reviewers to conduct...
The Department of Health and Human Services, Food and Drug Administration awarded a fixed-price purchase order contract to Certara USA Inc., doing business as Tripos (De), for an annual Phoenix Quantum software subscription. The contract, with a potential value of $216,547.78, provides the FDA's Office of Clinical Pharmacology with the necessary modeling and simulation tools to analyze and verify sponsor submissions, including Investigational New Drug, New Drug, Biologics Licensing, and...
This is a $169,504.71 firm-fixed price purchase order awarded by the U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), a technology-enabled drug development and drug safety consultancy. The contract provides annual named user server licenses for Certara's Phoenix WinNonlin, Phoenix Connect, Phoenix NLME software, as well as an unlimited server license for distributed computing. This supports the FDA's...
The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Certara UK Limited, doing business as Certara, a for-profit limited liability company, for SIMCYP software licenses and maintenance support. The $114,316.00 contract will allow the FDA's Office of Clinical Pharmacology Drug Reviewers to complete their review of investigational new drugs. Certara has previously provided this physiologically-based pharmacokinetic modeling software to the FDA and...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order contract to Certara USA Inc. for the procurement of the Phoenix WinNonlin software. The contract has a potential value of $19,950.00 and a completion date of May 31, 2025. This contract supports federal scientists and reviewers in conducting clinical pharmacology, pharmacometric, and regulatory review analyses on...
This is a firm fixed-price purchase order awarded by the National Institutes of Allergy and Infectious Diseases (NIAID) to Pharsight Corporation, a subsidiary of Certara USA Inc. The contract, valued at $3,716.00, does not have a set-aside designation. The award is likely related to NIAID's drug development and evaluation programs, as Certara's software and consulting services support clinical pharmacology, pharmacometric, and regulatory review activities for government agencies. The award may...